Erectile dysfunction drug Stendra approved by FDA
New erectile dysfunction drug Stendra given go-ahead by FDA.
The US Food and Drug Administration approved Friday a new drug to treat erectile dysfunction.
Stendra, from Vivus Inc. is the newest drug in a line of phosphodiesterase type 5 (PDE5) inhibitors, which include drugs like Viagra and Levitra.
These drugs boost blood flow to the penis, reported the Wall Street Journal, and help men to sustain erection – a common problem in older men.
“This approval expands the available treatment options to men experiencing erectile dysfunction, and enables patients, in consultation with their doctor, to choose the most appropriate treatment for their needs,” said Victoria Kusiak, M.D., deputy director of the Office of Drug Evaluation III in the FDA’s Center for Drug Evaluation and Research, reported WebMd.
Stendra, the brand name for avanafil, is taken in 50, 100 or 200 milligram doses 30 minutes before sexual activity.
Researchers have said that Stendra worked as early as 15 minutes after taking it in some patients, which would make it work twice as fast as competitor Viagra, said ABC News.
The side effects of Stendra are shared by similar drugs and include headache, flushing and back pain – along with the possibility of an erection that lasts far longer than usual.
Read more on GlobalPost: Should the EU give up on green energy?
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.